Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of New Potential Biomarkers of Lymphangioleiomyomatosis: Determination of Cathepsin K, Cystatin C, Collagen Telopeptides and Chondroitin Sulfates

NCT05323370 is registered in ClinicalTrials.gov with University Hospital, Tours as lead sponsor.

NCT NCT05323370
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05323370 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of New Potential Biomarkers of Lymphangioleiomyomatosis: Determination of Cathepsin K, Cystatin C, Collagen Telopeptides and Chondroitin Sulfates
Lead sponsor
University Hospital, Tours
Phase
Observational
Overall status
Completed
Start date
May 31, 2022
Completion date
October 30, 2022
Enrollment
19 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lymphangioleiomyomatosis, tuberous sclerosis complex